Urology Medical News about muscarinic receptor

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Attenuation of Non-neuronal Adenosin Triphosphate Release from Human Bladder Mucosa by Antimuscarinic Agents
LUTS: Lower Urinary Tract Symptoms, 10/05/09

Yoshida M et al. – The data suggest that human bladder mucosa is a main source of stretch–induced non–neuronal ATP release, and that stimulation of M2 and M3 receptor subtypes of mucosa partly contributes to non–neuronal ATP release. Various antimuscarinic drugs used for the treatment of overactive bladder may have different inhibitory effects on non–neuronal ATP release.

<< Previous
Experience with Tension-free Vaginal Tape (TVT)-SECUR for Female...

Next >>
Tips on Outsourcing Claims Editing

Nitric oxide synthase 1 and cyclooxygenase-2 enzymes are targets of muscarinic activation in normal and inflamed NIH3T3 cells
Inflammation Research, 10/26/09 Relevance Score: 65%

Pharmacological treatment of benign prostatic hyperplasia
Der Urologe, 10/29/09 Relevance Score: 64%

Cholinergic Functioning in Stimulant Addiction: Implications for Medications Development
CNS Drugs, 10/26/09 Relevance Score: 64%

Activating Autoantibodies to the Beta-1 Adrenergic and M2 Muscarinic Receptors Facilitate Atrial Fibrillation in Patients With Graves' Hyperthyroidism
JACC - Journal of the American College of Cardiology, 10/05/09 Relevance Score: 64%

Targeting the NMDA Receptor Subunit NR2B for the Treatment of Neuropathic Pain
Neurotherapeutics, 10/05/09 Relevance Score: 47%